An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
https://www.nist.gov/people/zvi-kelman
Zvi Kelman (Fed)
Research Biologist
Zvi is the director of the Biomolecular Labeling Laboratory (BL2) at theNational Institute of Standards and Technology (NIST). He is also a Fellow at theInstitute for Bioscience and Biotechnology Research (IBBR) and an adjunct Professor atDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park. He is also affiliated with the Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine and he is a member of the Biological Science (BISI) program at the University of Maryland, College Park, the Marine Estuarine Environmental Sciences (MEES), University of Maryland and the Program in Oncology, University of Maryland School of Medicine.
Zvi earned a B.Sc. in Agriculture from the Hebrew University in Jerusalem and a M.Sc. in Cell Biology from the Weizmann Institute of Science. After receiving a Ph.D. in Molecular Biology from the Cornell University Graduate School of Medical Sciences, he was a Helen Hay Whitney Foundation Post-Doctoral Fellow in the laboratories of Thomas Kelly (Johns Hopkins University) and Jerard Hurwitz (Memorial Sloan-Kettering Cancer Center). Upon completion of his postgraduate training, he became a Life Technologies Professor at the Center for Advanced Research in Biotechnology (CARB), University of Maryland Biotechnology Institute (UMBI). Dr. Kelman moved to the University of Maryland, College Park in 2010 and to his current position at NIST in 2011.
Next-generation approaches for protein sequencing are now emerging that could have the potential to revolutionize the field in proteomics. One such sequencing
Nicholas Callahan, Jennifer A. Tullman, John Marino, Zvi Kelman
Proteomic analysis can be a critical bottleneck in cellular characterization. The current paradigm relies primarily on mass spectrometry of peptides and
Erik M. Leith, William Brad O'Dell, Na Ke, Colleen McClung, Mehmet Berkmen, Christina Bergonzo, Robert G. Brinson, Zvi Kelman
Monoclonal antibodies (mAbs) represent an important platform for the development of biotherapeutic products. While most mAbs are produced in mammalian cells
One of the central challenges in the development of single-molecule protein sequencing technologies is achieving high-fidelity, sequential recognition and